LIFECARE AS NOK 040
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue. Lifecare AS was founded in 2006 and is based in Bergen, Norway.
LIFECARE AS NOK 040 (LFC) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, LIFECARE AS NOK 040 (LFC) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
LIFECARE AS NOK 040 - Net Assets Trend (None–None)
This chart illustrates how LIFECARE AS NOK 040's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LIFECARE AS NOK 040 (None–None)
The table below shows the annual net assets of LIFECARE AS NOK 040 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to LIFECARE AS NOK 040's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
LIFECARE AS NOK 040 Competitors by Market Cap
The table below lists competitors of LIFECARE AS NOK 040 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cult Food Science Corp
OTCQB:CULTF
|
$1.76 Million |
|
Spindletop O&G
PINK:SPND
|
$1.76 Million |
|
J.B.HUNT TRANSP
MU:JB1
|
$1.76 Million |
|
PortfolioMan Hammers Fonde-Forsvar kl n
CO:PMIFOR
|
$1.76 Million |
|
Millennium Pharmacon International
JK:SDPC
|
$1.76 Million |
|
Nevis Brands Inc.
OTCQB:NEVIF
|
$1.76 Million |
|
Hypebeast Limited
PINK:HYPPF
|
$1.76 Million |
|
Mojo Organics Inc.
OTCQB:MOJO
|
$1.76 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LIFECARE AS NOK 040's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares LIFECARE AS NOK 040's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently LIFECARE AS NOK 040 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares LIFECARE AS NOK 040's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LIFECARE AS NOK 040 (LFC) | €- | N/A | N/A | $1.76 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |